Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation

A. Goolaerts, V. Vanneaux, J. Larghero, M. Matthay, C. Clérici (Paris, France)

Source: Annual Congress 2011 - Lung cell injury and repair
Session: Lung cell injury and repair
Session type: Poster Discussion
Number: 4589

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Goolaerts, V. Vanneaux, J. Larghero, M. Matthay, C. Clérici (Paris, France). Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation. Eur Respir J 2011; 38: Suppl. 55, 4589

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

The secretome of lung resident mesenchymal stem cells is anti-fibrotic in vitro and in vivo
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018



LSC Abstract – Network analysis of induced pluripotent stem cells secretome reveales its anti fibrotic action in rat lung injury model
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016


Using induced pluripotent stem cells to model the human lung alveolar epithelium
Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Year: 2018

The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury.
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019

Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012



Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010


Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018


Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro
Source: ERS Lung Science Conference 2018
Year: 2018

3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021


IPF lung resident mesenchymal stem cells differentiate into epithelial cells displaying a disease-specific transcriptome
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019



Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015



Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020

Therapeutic effects of human perivascular stem cells in an emphysema mouse model
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017

Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009



The role of resident lung mesenchymal stromal cells in normal and aberrant lung development
Source: Virtual Congress 2020 – Cellular involvement in lung injury
Year: 2020




Identification of MSC-like cells in human lung parenchyma capable of differentiating into airway epithelial cells
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009